Featured Research

from universities, journals, and other organizations

Targeting Sugars May Revolutionize Treatment Of Bone Disorders

Date:
October 10, 2007
Source:
American Chemical Society
Summary:
One of the most fundamental scientific beliefs about the structure of human bone is apparently incomplete -- a finding scientists say could have sweeping impact on treatments for osteoporosis and other bone disorders. Their study concludes that sugars, not proteins, are key organic building blocks that account for bone's toughness and stiffness.

Researchers in the United Kingdom and Germany are reporting that one of the most fundamental scientific beliefs about the structure of human bone is incomplete -- a finding they say could have sweeping impact on treatments for osteoporosis and other bone disorders. Their study concludes that sugars, not proteins, are key organic building blocks that account for bone's toughness and stiffness.

The University of Cambridge's David G. Reid and Melinda Duer and Christian Jaeger at and Federal Institute of Materials Research and Testing in Berlin, explain that scientists have long held that collagen and other proteins were the main organic molecules responsible for stabilizing normal bone structure.

That belief has been the basis for existing medications for bone disorders, and bone replacement materials. At the same time, researchers paid little attention to roles of sugars (carbohydrates) in the complex process of bone growth.

In the new report, researchers describe experiments on mineralization in horse bones using an analysis tool called nuclear magnetic resonance (NMR). They found that sugars, particularly proteoglycans and glycosaminoglycans, appear to play a larger role than proteins in controlling the bone mineralization process and may be a key to maintaining healthy bones.

"This could exert a major impact on the pharmacological management of bone disorders by directing novel therapeutic approaches, as it suggests new molecular targets for drug discovery," the report states. "It also offers new disease biomarkers for diagnosis."

"Organic-Mineral Interface in Bone is Predominately Polysaccharide" is scheduled for the Oct. 16 issue of ACS' Chemistry of Materials.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Targeting Sugars May Revolutionize Treatment Of Bone Disorders." ScienceDaily. ScienceDaily, 10 October 2007. <www.sciencedaily.com/releases/2007/10/071008093002.htm>.
American Chemical Society. (2007, October 10). Targeting Sugars May Revolutionize Treatment Of Bone Disorders. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2007/10/071008093002.htm
American Chemical Society. "Targeting Sugars May Revolutionize Treatment Of Bone Disorders." ScienceDaily. www.sciencedaily.com/releases/2007/10/071008093002.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins